July 11, 2024
Open to all ISPOR Members and Non-members
Title: IRA Part II: Next 15 For Medicare Drug Price Negotiations in 2025
Thursday, July 11, 2024
1:00PM EDT | 5:00PM UTC | 7:00PM CEST
Click here for time zone conversion
Register Now
Following their standing-room only Spotlight session at ISPOR 2024 in Atlanta, "Medicare Drug Price Negotiation: Lessons from the First 10 Drugs Selected," Drs Inma Hernandez, Sean Sullivan, and Emma Cousin provide a new analysis of which drugs may be next for price negotiations. This session will be highly relevant for professionals and researchers in market access, pricing, and HEOR.
The webinar will begin with an introduction of the eligibility criteria for selection of drugs for Medicare drug negotiation. Speakers will review the eligibility of top Part D drugs according to projected 2023 spending for selection for negotiation in CMS' second cycle (February 2025). They will present their forecasts for the list of products likely subject for negotiation and discuss why other drugs with comparable levels of gross spending are likely to be ineligible.
Additional Resources
Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025Learning Objectives
- Introduce the eligibility criteria for selection of drugs for Medicare drug price negotiation.
- Share methods used to forecast the list of products likely subject to negotiation.
- Describe the key factors that may lead to some drugs with comparable levels of gross spending to be ineligible for price negotiations.
Speakers:
Inmaculada Hernandez, PhD, Professor, Division of Clinical Pharmacy, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, USA
Sean D. Sullivan, BscPharm, PhD, Professor of Pharmacy and Public Health, The CHOICE Institute, University of Washington, Seattle, WA, USA
Emma M. Cousin, PharmD, PhD Student, The CHOICE Institute, University of Washington, Seattle, WA, USA
Brought to you by: ISPOR
Please note: This webinar will only be presented live on Thursday, July 11. The webinar recording will not be distributed for on-demand viewing. On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. Reservations are on a first-come, first-served basis.